Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Tafamidis efficacy among octogenarian patients in the phase 3 ATTR-ACT and ongoing long-term extension study PC91 (#9)
  1. Home
  2. Publications
  3. Tafamidis efficacy among octogenarian patients in the phase 3 ATTR-ACT and ongoing long-term extension study PC91 (#9)

Tafamidis efficacy among octogenarian patients in the phase 3 ATTR-ACT and ongoing long-term extension study PC91 (#9)

Authors:
  • PGPablo Garcia-Pavia
    Pablo Garcia-Pavia
  • MBMarla B.
    Marla B.
  • BGBalarama Gundapaneni
    Balarama Gundapaneni
  • YSYoshiki Sekijima
    Yoshiki Sekijima
  • FPFederico Perfetto
    Federico Perfetto
  • MHMazen Hanna
    Mazen Hanna
  • RWRonald Witteles
    Ronald Witteles

Publisher website
Google Scholar
  • 7 May 2024
    • conference paper
    • Published by Morressier GmbH
    • DOI:10.26226/m.65f9bf89e6f73964e1d4e7ce
Abstract
**Author Listing - Lead/ Submitting Author (we will be communicating with this individual): Name, Institution, City and State where the work was | POSTER
Keywords
  • AUTHOR LISTING
  • SUBMITTING AUTHOR
  • TAFAMIDIS EFFICACY
  • EXTENSION STUDY
  • OCTOGENARIAN PATIENTS
  • ONGOING LONG-TERM
  • LONG-TERM EXTENSION
  • LEAD
  • INSTITUTION
  • POSTER
Cited by 1 article
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.